Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$998,212
-$146,433 QoQ
Shares Held
7,901
-3.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#1,069
of 2,265 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ATLAS CAPITAL ADVISORS INC. holds $9,612,551 across 15 Drug Manufacturers - General names. GILD ranks #2 (10.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,869 | $4,640,595 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
7,901 | $998,212 | |
| 3 | MRK |
Merck & Co., Inc.
|
5,216 | $670,256 | |
| 4 | BIIB |
Biogen Inc.
|
2,930 | $633,055 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
10,844 | $624,831 | |
| 6 | AZN |
Astrazeneca PLC
|
2,976 | $564,309 | |
| 7 | AMGN |
Amgen Inc
|
1,185 | $429,112 | |
| 8 | GRFS |
Grifols SA
|
31,637 | $223,989 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $998,212 | 7,901 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,144,645 | 8,213 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,010,641 | 8,234 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $943,392 | 8,509 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,136,971 | 10,147 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $798,261 | 8,642 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $743,912 | 8,873 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $340,923 | 4,969 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $446,605 | 6,097 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $575,495 | 7,104 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $492,355 | 6,570 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $523,921 | 6,798 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $705,079 | 8,498 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $1,333,078 | 15,528 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $359,220 | 5,823 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $473,217 | 7,656 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $451,225 | 7,590 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $551,109 | 7,590 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $530,161 | 7,590 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $522,647 | 7,590 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $485,759 | 7,516 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $331,965 | 5,698 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $347,229 | 5,495 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $470,334 | 6,113 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $457,007 | 6,113 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||